← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 27.2% to $32.0M, while Net income decreased 17.5% to ($14.0M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $32.0MWatch
- Profitability — Net income ($14.0M)Watch
- Cash generation — Free cash flow ($8.3M)Note
- Accounting — Formula distress score · no manipulation flag · earnings quality safeWatch
- Insiders — 3 buys; 3 sells in 365 daysOK
- Capital — Comparable payout data unavailableNote
Business
electroCore, Inc.: We have a limited history commercializing our Quell platform and our general wellness and human performance products in the United States for which market acceptance and commercial success are uncertain.
Where the revenue comes from
Fiscal 2025, as electroCore, Inc. reports it. History and quarterly detail are in the app.
Leadership changes
From electroCore, Inc.'s own filings, the day they're filed.
- Thomas J. Errico · chairman · appointmenteff. 2025-09-02
- Elena Bonfiglioli · director · appointmenteff. 2025-09-02
- Charles S. Theofilos · member · departureeff. 2025-02-24
Latest filings
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-06
- DEF 14A · Annual proxy (pay & governance)2026-07-20
- 10-Q · Quarterly report2026-05-06
- 8-K · Company announcement2026-05-06
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about electroCore, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.